Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts

Frederick G. Hayden

Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville

Masaharu Shinkai

Department of Respiratory Medicine, Tokyo Shinagawa Hospital, Tokyo

Tristan W. Clark

School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

Anne F. Luetkemeyer

Division of HIV, Infectious Diseases and Global Medicine, Zuckerberg San Francisco General, University of California, San Francisco, San Francisco

Paul E. Sax

Harvard Medical School and Brigham and Women’s Hospital, Boston

William P. Hanage

Kelly A. Gebo

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore

Hideyuki Ikematsu

Ricerca Clinica, Fukuoka, Japan

Koichi Izumikawa

Akimasa Fukushi

Drug Development and Regulatory Science Division, Shionogi, Osaka, Japan

Safwan Kezbor

Clinical Development, Shionogi, Florham Park, NJ

Hiroki Sakaguchi

Drug Development and Regulatory Science Division, Shionogi, Osaka, Japan

Stuart Lacey

Biostatistics, Shionogi, London

Genki Ichihashi

Drug Development and Regulatory Science Division, Shionogi, Osaka, Japan

Norio Ohmagari

Takeki Uehara

Drug Development and Regulatory Science Division, Shionogi, Osaka, Japan